Moderna’s stock jumps after biotech raises sales outlook

MarketWatch · Jaimy Lee · 2026-11-06 12:15 UTC

The company lifted its revenue outlook for the year, saying it now expects revenue to grow as much as 25% in 2026

The company lifted its revenue outlook for the year, saying it now expects revenue to grow as much as 25% in 2026

Referenced Symbols

Moderna, which is best known for advancing the science of mRNA technology, raised its revenue outlook for the year, saying it now expects revenue to grow as much as 25% in 2026.

Read the full story at MarketWatch · All coverage of this story